Clinical Trials Directory

Trials / Completed

CompletedNCT03535844

Cardio-vascular Protective Effects of Wolfberry in Middle-aged and Older Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
41 (actual)
Sponsor
National University of Singapore · Academic / Other
Sex
All
Age
50 Years – 75 Years
Healthy volunteers
Accepted

Summary

This purpose of this study is to assess the impact of consuming wolfberry on cardiovascular risk in Singapore's middle-aged and older adults. The investigators hypothesize that consuming wolfberry with a healthy eating pattern diet will contribute to improvements in cardiovascular health when compared to a similar diet without wolfberry.

Detailed description

This is a 16-week parallel, single-blind (investigator), prospective randomized controlled trial. The study was designed based on previous research which showed that consuming 15 g/day of wolfberry for 4 weeks and 14 g/day of wolfberry with meal for 6 weeks increased plasma zeaxanthin concentrations and antioxidant status. Also, other studies reported observable changes in the endothelial progenitor cells and flow mediated dilation after just two weeks of fruit and vegetables or healthy diet interventions. Thus collectively, 16-weeks may be a sufficient period to detect the changes in endothelial function, whole body carotenoids, and anti-oxidant status, which are the outcomes of interest in this research project.

Conditions

Interventions

TypeNameDescription
OTHERWolfberryConsumption of cooked dehydrated wolfberry as part of a mixed meal.
OTHERHealthy dietCompliance to a healthy diet in accordance to recommendations by the Singapore Health Promotion Board.

Timeline

Start date
2018-08-06
Primary completion
2019-09-26
Completion
2019-09-26
First posted
2018-05-24
Last updated
2020-04-22
Results posted
2020-04-01

Locations

2 sites across 1 country: Singapore

Source: ClinicalTrials.gov record NCT03535844. Inclusion in this directory is not an endorsement.